Year: 2026
Type: article
Study design: Case Report
Abstract: This case report describes the use of targeted intracordal bevacizumab therapy for recurrent vocal fold hemorrhage refractory to conventional treatment. The intervention was associated with resolution of hemorrhagic episodes and sustained clinical improvement over follow-up. These findings suggest a potential role for antiangiogenic therapy in selected cases.
Source: The Laryngoscope
DOI: 10.1002/lary.70608
Authors: Andrés Lanas Volz, Camila Ramírez Pelayo
Institution: Universidad de Los Andes, Chile
Language: English
Topic: Voice and Speech Disorders
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7160937454